Bringing innovative healthcare technologies to the right patients, at the right price
Working with pharmaceutical and biotech companies as a trusted partner to explore the full potential of your technology within HTA markets worldwide.
Working with pharmaceutical and biotech companies as a trusted partner to explore the full potential of your technology within HTA markets worldwide.
With more than 20 years of experience, our team of health economists, market access experts, biostatisticians, clinicians, regulatory experts and communicators specialists, enable access to medical innovations across multiple therapeutic areas for public reimbursement.
LEARN MORE ABOUT US"The strategic insights provided by HEOR Value Hub were instrumental in our successful submission journey."
VP Market Access
Biotech Global
"HEOR Value Hub's rigorous approach to health economic modelling gave us the confidence to navigate complex HTA submissions across multiple markets."
Head of Market Access
Pharma Europe
"Their expertise in rare diseases and orphan indications is unmatched. A true partner throughout our reimbursement journey."
Director HTA Strategy
Rare Disease Biotech
We support pharmaceutical, biotechnology, and medical device companies at every stage of their market access journey, from early value strategy through evidence generation & synthesis, health economic modelling, post hoc analyses of trials and observational data, value dissemination, reimbursement submission and support during the post submission period.
Receive strategic market access insights, policy updates, and HTA news directly to your inbox.